Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.

Schizophrenia research - 1 Oct 2009

Irvin M R, Wiener H W, Perry R P, Savage R M, Go R C P

Abstract excerpt

An increased prevalence of type 2 diabetes (T2D) in schizophrenia (SCZ) patients has been observed. Exposure to antipsychotics (APs) has been shown to induce metabolic dysregulation in some patients but not all treated patients. We hypothesized that important candidate genes for T2D may increase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Black or African American
Share to Calpain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phosphoric Diester Hydrolases

Share to Psychotic Disorders

Share to Pyrophosphatases

Share to TCF Transcription Factors

Share to Transcription Factor 7-Like 2 Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 19643578
DOI: 10.1016/j.schres.2009.07.008
PMCID: PMC2753171

Genes

CAPN10
ENPP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19643578-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.PMID 19643578Read ↗

At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.Semantic proximity Read ↗

A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women.Semantic proximity Read ↗

Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives.Semantic proximity Read ↗

Lipid-lowering and glucose-lowering drug targets differentially modulate antipsychotic treatment efficacy in schizophrenia.Semantic proximity Read ↗

Polygenic risk score for schizophrenia was not associated with glycemic level (HbA1c) in patients with non-affective psychosis: Genetic Risk and Outcome of Psychosis (GROUP) cohort study.Semantic proximity Read ↗

The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first-episode drug-naive schizophrenic patients.Semantic proximity Read ↗

Schizophrenia, antipsychotics and diabetes: Genetic aspects.Semantic proximity Read ↗

Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample.Semantic proximity Read ↗

Metabolic Response to Olanzapine in Healthy Chinese Subjects with rs7093146 Polymorphism in Transcription Factor 7-like 2 Gene (TCF7L2): A Prospective Study.Semantic proximity Read ↗

Modulation ofTcf7l2 expression alters behavior in mice.Semantic proximity Read ↗

Parental type 2 diabetes in patients with non-affective psychosis.Semantic proximity Read ↗

Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.